JP2010507649A - アレルギーの予防及び治療のための医薬を調製するためにサイモシンアルファ１の使用 - Google Patents

アレルギーの予防及び治療のための医薬を調製するためにサイモシンアルファ１の使用 Download PDF

Info

Publication number
JP2010507649A
JP2010507649A JP2009534060A JP2009534060A JP2010507649A JP 2010507649 A JP2010507649 A JP 2010507649A JP 2009534060 A JP2009534060 A JP 2009534060A JP 2009534060 A JP2009534060 A JP 2009534060A JP 2010507649 A JP2010507649 A JP 2010507649A
Authority
JP
Japan
Prior art keywords
allergies
treatment
prevention
thymosin alpha
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009534060A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010507649A5 (https=
Inventor
ロマーニ、ルイジーナ
ビストーニ、フランチェスコ
ガラチ、エンリコ
ラシ、グイード
ヴァッレボーナ、パオラ シニバルディ
Original Assignee
シグマ − タウ インデュストリエ ファーマシューティッツェ リウニーテ ソシエタ ペル アチオニ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シグマ − タウ インデュストリエ ファーマシューティッツェ リウニーテ ソシエタ ペル アチオニ filed Critical シグマ − タウ インデュストリエ ファーマシューティッツェ リウニーテ ソシエタ ペル アチオニ
Publication of JP2010507649A publication Critical patent/JP2010507649A/ja
Publication of JP2010507649A5 publication Critical patent/JP2010507649A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2009534060A 2006-10-27 2007-09-27 アレルギーの予防及び治療のための医薬を調製するためにサイモシンアルファ１の使用 Pending JP2010507649A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000583A ITRM20060583A1 (it) 2006-10-27 2006-10-27 Uso della timosina alfa 1 per la preparazione di un medicamento per la prevenzione e la cura delle allergie
PCT/IT2007/000676 WO2008050362A2 (en) 2006-10-27 2007-09-27 Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies

Publications (2)

Publication Number Publication Date
JP2010507649A true JP2010507649A (ja) 2010-03-11
JP2010507649A5 JP2010507649A5 (https=) 2010-11-11

Family

ID=39322638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009534060A Pending JP2010507649A (ja) 2006-10-27 2007-09-27 アレルギーの予防及び治療のための医薬を調製するためにサイモシンアルファ１の使用

Country Status (13)

Country Link
US (1) US20090270594A1 (https=)
EP (1) EP2083847A2 (https=)
JP (1) JP2010507649A (https=)
KR (1) KR20090092267A (https=)
CN (1) CN101626778A (https=)
AU (1) AU2007310415A1 (https=)
BR (1) BRPI0718019A2 (https=)
CA (1) CA2666562A1 (https=)
EA (1) EA200900603A1 (https=)
IL (1) IL198290A0 (https=)
IT (1) ITRM20060583A1 (https=)
MX (1) MX2009004237A (https=)
WO (1) WO2008050362A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6984522B2 (en) 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002524031A (ja) * 1998-07-30 2002-08-06 ルーヴェン リサーチ アンド ディベロップメント ヴィゼットダヴリュ アレルギーの予防および／または治療のための化合物と方法
JP2005247709A (ja) * 2002-08-30 2005-09-15 Immunofrontier:Kk 制御性ｔ細胞の活性を制御する方法および組成物
JP2006521406A (ja) * 2003-03-28 2006-09-21 サイクローン・ファーマシューティカルズ・インコーポレイテッド チモシンα１によるアスペルギルス感染の治療

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002524031A (ja) * 1998-07-30 2002-08-06 ルーヴェン リサーチ アンド ディベロップメント ヴィゼットダヴリュ アレルギーの予防および／または治療のための化合物と方法
JP2005247709A (ja) * 2002-08-30 2005-09-15 Immunofrontier:Kk 制御性ｔ細胞の活性を制御する方法および組成物
JP2006521406A (ja) * 2003-03-28 2006-09-21 サイクローン・ファーマシューティカルズ・インコーポレイテッド チモシンα１によるアスペルギルス感染の治療

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6012039261; Ｌ．Ｒｏｍａｎｉ　ｅｔ　ａｌ．: Ｂｌｏｏｄ ｖｏｌ．１０８，　Ｎｏ．７, 20061001, ｐ．２２６５-２２７４ *
JPN6012040103; Ｌ．Ｒｏｍａｎｉ　ｅｔ　ａｌ．: Ｂｌｏｏｄ ｖｏｌ．１０３，　Ｎｏ．１１, 20040601, ｐ．４２３２-４２３９ *

Also Published As

Publication number Publication date
CA2666562A1 (en) 2008-05-02
WO2008050362A3 (en) 2008-07-10
EP2083847A2 (en) 2009-08-05
ITRM20060583A1 (it) 2008-04-28
EA200900603A1 (ru) 2009-10-30
AU2007310415A1 (en) 2008-05-02
MX2009004237A (es) 2009-07-07
BRPI0718019A2 (pt) 2013-11-19
CN101626778A (zh) 2010-01-13
US20090270594A1 (en) 2009-10-29
IL198290A0 (en) 2011-08-01
KR20090092267A (ko) 2009-08-31
WO2008050362A2 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
Ebihara et al. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis
Hao et al. Diesel exhaust particles exert acute effects on airway inflammation and function in murine allergen provocation models
Siebeneicher et al. Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model
Chen et al. Glycyrrhizin ameliorates experimental colitis through attenuating interleukin-17-producing T cell responses via regulating antigen-presenting cells
JP2020109128A (ja) 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト
JP2002509074A (ja) 熱ショックタンパク質を使用する、炎症性疾患を処置する方法
WO2009049215A1 (en) Methods to reduce the effects of sleep deprivation
JP2013541010A (ja) グラチラマーアセテートに対する臨床的な反応の予測可能なバイオマーカーとしてのサイトカインバイオマーカー
AU2014249456A1 (en) Use of levocetirizine and montelukast in the treatment of autoimmune disorders
Secor Jr et al. Bromelain limits airway inflammation in an ovalbumin-induced murine model of established asthma
US20030096736A1 (en) Lactoferrin for age related disorders in humans
Zhu et al. Edaravone alleviated allergic airway inflammation by inhibiting oxidative stress and endoplasmic reticulum stress
Zhao et al. Matrine suppresses production of IL-23/IL-17 and ameliorates experimental autoimmune encephalomyelitis
JP2010507649A (ja) アレルギーの予防及び治療のための医薬を調製するためにサイモシンアルファ１の使用
Aizman et al. The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice
US20180148489A2 (en) Idr peptide compositions and use thereof for treatment of th2-dysregulated inflammatory conditions
US7691809B2 (en) Lactoferrin for age related disorders in humans
TW202340233A (zh) 肽用於治療神經退行性疾病或改善認知功能的用途
Hung et al. Regulation of stromal cell-derived factor-1 and exhaled nitric oxide in asthmatic children following montelukast and ketotifen treatment
HK1138513A (en) Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies
JP2010507650A (ja) 自己免疫疾患の予防及び治療用の薬剤を調製するためのチモシンアルファ１の使用
CN109771446A (zh) 唾液链球菌k12在制备预防和/或治疗自身免疫性疾病的药物中的应用
Souza et al. Recombinant 60-kDa heat shock protein from Paracoccidioides brasiliensis induces the death of mouse lymphocytes in a mechanism dependent on Toll-like receptor 4 and tumor necrosis factor
US20060074049A1 (en) Use of heparinoids for treatment and prevention of dementia
WO2009040849A1 (en) Use of amino acid l-kynurenine and derivatives thereof for the treatment of chronic inflammatory pathologies

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100924

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100924

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120803

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130108